Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model

Author：                    

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.6, Iss.3, 2013-01, pp. : 667-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma

By                

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 712-720

Spandidos Publications

Access to resources Recommend Favorite

5fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma

By                    

Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. : 1195-1202

Spandidos Publications

Access to resources Recommend Favorite

Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat

By Holst-Hansen C.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 3, 2001-08 ,pp. : 225-237

Springer Publishing Company

Access to resources Recommend Favorite

Camptothecin analogues and vinblastine in the treatment of renal cell carcinoma: an in vivo study using a human orthotopic renal cancer xenograft

By El-Galley R.   Keane T.E.   Sun C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 1, 2003-01 ,pp. : 49-57

Elsevier

Access to resources Recommend Favorite

A multicenter, phase II study of the RAF-kinase inhibitor sorafenib in patients with advanced renal cell carcinoma

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1099-1102

Science Publishers

Access to resources Recommend Favorite